Fundraising Fox

Alan Walts

Investor

Venture Partner at Advent Life Sciences

Massachusetts

Writes $25K – $5M checks Β· typically $1M

About

Alan E. Walts joined Advent Life Sciences in 2013 after 27 years at Genzyme Corporation, where his roles spanned corporate venture capital, business development, R&D, and general management. He most recently ran Genzyme's corporate venture fund (Genzyme Ventures, now Sanofi Ventures), and previously served as President of Genzyme Pharmaceuticals and head of chemistry and biopolymer research. He holds a Ph.D. in chemistry from MIT (1985), completed post-doctoral biochemistry research at MIT, and finished the executive Program for Management Development at Harvard Business School in 1993.

Invests in

Biotech

Experience

  1. Aleta BiotherapeuticsChief Executive Officercurrent2025 β€” present
  2. Aleta BiotherapeuticsExecutive Chairman2025
  3. Advent Life Sciences LLPVenture Partnercurrent2014 β€” present
  4. AlphaRose TherapeuticsCo-founder and Executive Chairmancurrent2024 β€” present
  5. Eloxx PharmaceuticalsChairmancurrent2021 β€” presentWatertown, Massachusetts, United States
  6. Termeer InstituteBoard Member and Treasurercurrent2019 β€” presentMarblehead, MA
  7. Artax Biopharma IncBoard Membercurrent2017 β€” presentCambridge, MA
  8. PIC TherapeuticsBoard Membercurrent2016 β€” presentGreater Boston Area
  9. NeuroelectricsBoard Membercurrent2021 β€” present
  10. NeuroelectricsBusiness and Strategy Advisor2015 β€” 2021Cambridge, MA
  11. Hemogenyx PharmaceuticalsAdvisor and Board Observercurrent2021 β€” presentBrooklyn, New York, United States
  12. ALS Investment FundAdvisory Board Membercurrent2018 β€” presentCambridge, MA
  13. Arrakis TherapeuticsBoard Observercurrent2019 β€” presentWaltham, MA
  14. Arrakis TherapeuticsFounder and Board Member2016 β€” 2019Cambridge, MA
  15. Arrakis TherapeuticsFounder and Executive Chairman2015 β€” 2016Boston, MA
  16. Termeer EstateBusiness Advisorcurrent2017 β€” present
  17. Zikani TherapeuticsExecutive Chairman2020 β€” 2021
  18. Zikani TherapeuticsCorporate Advisor2019 β€” 2020Watertown, MA
  19. Aura BiosciencesBoard Observer2019 β€” 2021Cambridge, MA
  20. Aura BiosciencesChairman2018 β€” 2019Cambridge, MA

Education

  1. Massachusetts Institute of TechnologyPost-Doctoral Studies, Biochemistry1985 β€” 1986
  2. Massachusetts Institute of TechnologyPh.D., Organic Chemistry1981 β€” 1985
  3. St. John Fisher CollegeBachelor of Science (B.S.), Chemistry1977 β€” 1981

Skills & more

Biotechnology16Lifesciences7Biopharmaceuticals23Venture Capital18Corporate Development24Strategy10Business Strategy4Start-ups7Board of DirectorsMergersOrganic Chemistry1Biochemistry3
+1 moreDue Diligence

From Alan's professional profile.

Same school

Shared employers

Deals Β· 2

Artax Biopharma, Inc.Board seat

via Advent Life Sciences Β· filed May 2026 Β· $19M raise

Arrakis TherapeuticsBoard seat

via Advent Life Sciences Β· filed Mar 2017 Β· $41.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Advent Life Sciences

Network5

Investors connected to Alan in public investor directories β€” a warm-intro map.